13F Data
Security · CUSIP 29014R301

ELOXX PHARMACEUTICALS INC

COM NEW · institutional ownership from 13F filings
13F holders
22
Shares held
2.9M
Value held
$40.2M
New / sold out
22 / 0
Added / reduced
0 / 0
net +2.9M shares

13F holders by quarter

Q2 2026: 22Q3 2026: 6
Q2 2026Q3 2026

Net shares bought by existing holders

Q2 2026: 2.9MQ3 2026: 19.9K
Q2 2026Q3 2026

Top holders · Q2 2026

ManagerSharesValue% of portfolio
Nantahala Capital Management, LLC800,000$11.1M0.18%
EcoR1 Capital, LLC400,000$5.6M0.27%
SAMSARA BIOCAPITAL, LLC400,000$5.6M0.46%
Aberdeen Group plc400,000$5.6M0.01%
Siren, L.L.C.400,000$5.6M0.11%
Stonepine Capital Management, LLC397,160$5.5M3.11%
VANGUARD CAPITAL MANAGEMENT LLC78,680$1.1M0.00%
VANGUARD FIDUCIARY TRUST CO10,602$147.2K0.00%
SEVEN GRAND MANAGERS, LLC10,000$138.8K0.01%
MORGAN STANLEY1,544$21.4K0.00%
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest buyers

ManagerChangeShares changeChange %
Nantahala Capital Management, LLCNew+800,000–
EcoR1 Capital, LLCNew+400,000–
Siren, L.L.C.New+400,000–
Aberdeen Group plcNew+400,000–
SAMSARA BIOCAPITAL, LLCNew+400,000–
Stonepine Capital Management, LLCNew+397,160–
VANGUARD CAPITAL MANAGEMENT LLCNew+78,680–
VANGUARD FIDUCIARY TRUST CONew+10,602–
SEVEN GRAND MANAGERS, LLCNew+10,000–
MORGAN STANLEYNew+1,544–
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sellers

Nothing to show.